Home  »  Finance   »  BiondVax Pharmaceuticals Ltd. (BVXV): Get Prepared...

BiondVax Pharmaceuticals Ltd. (BVXV): Get Prepared for Trading Lift Off

BiondVax Pharmaceuticals Ltd. (BVXV) is priced at $1.07 after the most recent trading session. At the very opening of the session, the stock price was $0.93 and reached a high price of $1.18, prior to closing the session it reached the value of $0.96. The stock touched a low price of $0.93.Recently in News on September 22, 2022, BVXV: Results for Preclinical Inhalation Proof-of-Concept Study in COVID-19 Expected by End of This Year…. By David Bautz, PhD. You can read further details here

BiondVax Pharmaceuticals Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.4000 on 01/03/22, with the lowest value was $0.8882 for the same time period, recorded on 09/21/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


BiondVax Pharmaceuticals Ltd. (BVXV) full year performance was -54.85%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, BiondVax Pharmaceuticals Ltd. shares are logging -69.34% during the 52-week period from high price, and 20.47% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.89 and $3.49.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1339370 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the BiondVax Pharmaceuticals Ltd. (BVXV) recorded performance in the market was -54.47%, having the revenues showcasing -11.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 19.47M, as it employees total of 15 workers.

Market experts do have their say about BiondVax Pharmaceuticals Ltd. (BVXV)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2114, with a change in the price was noted -0.22. In a similar fashion, BiondVax Pharmaceuticals Ltd. posted a movement of -17.05% for the period of last 100 days, recording 55,362 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BVXV is recording 4.43 at the time of this writing. In addition, long term Debt to Equity ratio is set at 4.38.

Technical breakdown of BiondVax Pharmaceuticals Ltd. (BVXV)

Raw Stochastic average of BiondVax Pharmaceuticals Ltd. in the period of last 50 days is set at 45.25%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.30%. In the last 20 days, the company’s Stochastic %K was 33.57% and its Stochastic %D was recorded 20.89%.

Bearing in mind the latest performance of BiondVax Pharmaceuticals Ltd., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -54.47%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -21.90%, alongside a downfall of -54.85% for the period of the last 12 months. The shares increased approximately by 9.15% in the 7-day charts and went up by -7.76% in the period of the last 30 days. Common stock shares were lifted by -11.57% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts